Upgrade to SI Premium - Free Trial

Amarin (AMRN) Sues FDA; Seeks Five Year Vascepa Exclusivity

February 27, 2014 5:07 PM
Amarin Corp plc (Nasdaq: AMRN) has sued the U.S. FDA ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hot Corp. News Litigation

Next Articles